Arizona Executioners Had To Use 15 Doses of Lethal Drugs Before Inmate Finally Died

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Documents released Friday afternoon in the case of Arizona’s  botched execution of Joseph Wood—who gasped for air and struggled, according to witnesses, repeatedly during the two-hour process—show that  executioners used 15 separate doses of a new drug cocktail before Wood finally died. Lawyers had warned that the combination of 50 milligrams hydromorphone (a pain killer) and 50 milligrams of midazolam (a sedative) was rife with potential problems. (The state also has a long history of failing to follow its own protocol.) The documents suggest they were right.

“Instead of the one dose as required under the protocol, ADC injected 15 separate doses of the drug combination, resulting in the most prolonged execution in recent memory,” said Dale Baich, Wood’s lawyer. “This is why an independent investigation by a non-governmental authority is necessary.”

Ohio  used a similar drug cocktail in January to execute Dennis McGuire, who gasped and snorted for 25 minutes before finally succumbing, the longest execution in Ohio history. Arizona apparently increased the dosage of midazolam from what Ohio had used, but it doesn’t seem to have gotten any better results.

When officials in Ohio and elsewhere first expressed their intent to experiment with the midazolam/hydromorphone combination, experts predicted, as Mother Jones‘ Molly Redden reported, that little was known about how the new drug combinations would work in executions. She wrote:

Jonathan Groner, a professor of clinical surgery at the Ohio State University College of Medicine who has written extensively on the death penalty, says effects of a hydromorphone overdose include an extreme burning sensation, seizures, hallucination, panic attacks, vomiting, and muscle pain or spasms. [David Waisel, an associate professor of anesthesiology at Harvard Medical School], who has testified extensively on capital-punishment methods, adds that a hydromorphone overdose could result in soft tissue collapse—the same phenomenon that causes sleep apnea patients to jerk awake—that an inmate who had been paralyzed would be unable to clear by jerking or coughing. Instead, he could feel as though he were choking to death.

Because hydromorphone is not designed to kill a person, Groner says, there are no clinical guidelines for how to give a lethal overdose. “You’re basically relying on the toxic side effects to kill people while guessing at what levels that occurs,” he explains.

The new Arizona documents suggest that these assessments were dead on.

State officials are using new drug combinations because pharmaceutical companies have been refusing to sell or export the drugs traditionally used in executions. The US has seen a shortage of those drugs for several years now, and death penalty states have gone to increasingly desperate measures to kill their condemned, everything from illegally importing the old drugs to buying them from dubious compounding pharmacies. Arizona illustrated the latest gambit—using new combinations of other available drugs, something critics have called an unethical human experiment.

States have also gone to great lengths to hide information about the drugs they’re using in executions and how they’re getting them. In Arizona, Wood was just the latest of many death row inmates who have tried and failed to force states to be more transparent. The 9th Circuit Court of Appeals sided with Wood in late July and agreed that he had a right to know how he was going to die. But the US Supreme Court overruled that decision and allowed the execution to go forward.

 

 

 

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate